Abstract
Conflicting results are to be found in the literature on the relationship between the M235T polymorphism of the angiotensinogen (AGT) gene and hypertension. The controversy may be due to insufficient numbers of subjects, the variability of the inclusion criteria and the different genotype analysis methods used. We have experienced that the most frequently used, original polymerase chain reaction (PCR)−restriction fragment length polymorphism (RFLP) method involves significant uncertainties when the TT genotype is determined, independently of the restriction digestion. To make the determination more accurate, we improved the PCR by designing a new antisense primer containing only one mismatch instead of the two in the original protocol and also by adding DMSO to the PCR reaction mixture. The original and our improved methods were compared by using DNA from 123 patients: parallel determinations resulted in values of 33 MM, 90 MT and 0 TT with the original method and of 33 MM, 56 MT and 34 TT with the improved RFLP protocol. In summary, a plausible explanation for some of the conflicting data published on AGT M235T polymorphism may be that inaccuracies arose during the determination of the genotype.
Similar content being viewed by others
Article PDF
References
Kato N : Genetic analysis in human hypertension. Hypertens Res 2002; 25: 319–327.
Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R : M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9–17.
Russ AP, Maerz W, Ruzicka V, Stein U, Gross W : Rapid detection of the hypertension-associated Met235-Agt; Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2: 609–610.
Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular-basis of human hypertension—role of angiotensinogen. Cell 1992; 71: 169–180.
Kunz R, Kreutz R, Beige J, Distler A, Sharma AM : Association between the angiotensinogen 235T-variant and essential hypertension in whites—a systematic review and methodological appraisal. Hypertension 1997; 30: 1331–1337.
Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A : Angiotensinogen gene polymorphism, plasma angiotensinogen and risk of hypertension and ischemic heart disease—a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23: 1269–1275.
Kawada N, Moriyama T, Imai E, Hori M : Angiotensinogen gene polymorphism of threonine/methionine at position 235-potential problems of the modified restriction endonuclease (TTH111-I) digestion method. J Nephrol 1997; 10: 314–317.
Ward K, Hata A, Jeunemaitre X, et al: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4: 59–61.
Rodriguez-Perez JC, Rodriguez-Esparragon FJ, Hernandez-Perera O, Fiuza-Perez MD, Anabitarte-Prieto A, Losada-Cabrera A : Effects of the angiotensinogen gene M235T and A(-6)G variants on blood pressure and other vascular risk factors in a Spanish population. J Hum Hypertens 2000; 14: 789–793.
Bettinaglio P, Galbusera A, Caprioli J, et al: Single Strand Conformation Polymorphism (SSCP) as a quick and reliable method to genotype M235T polymorphism of angiotensinogen gene. Clin Biochem 2002; 35: 363–368.
Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T : Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521–525.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lizanecz, E., Pásztor, E., Mohácsi, A. et al. Mistyping of Angiotensinogen M235T Alleles. Hypertens Res 29, 197–201 (2006). https://doi.org/10.1291/hypres.29.197
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.29.197
Keywords
This article is cited by
-
The contribution of six polymorphisms to cardiovascular risk in a Dutch high-risk primary care population: the HIPPOCRATES project
Journal of Human Hypertension (2009)
